- Report
- January 2022
Japan, United States, ... Japan, United States, Europe, Global
From €17776EUR$18,500USD£15,285GBP
- Report
- July 2021
- 800 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €26424EUR$27,500USD£22,721GBP
- Report
- January 2021
- 465 Pages
United States
From €4660EUR$4,850USD£4,007GBP
- Report
- January 2021
- 775 Pages
United States, Europe, ... United States, Europe, Global
From €26424EUR$27,500USD£22,721GBP
- Report
- June 2020
- 460 Pages
United States
From €4660EUR$4,850USD£4,007GBP
- Report
- November 2019
- 775 Pages
United States, Europe, ... United States, Europe, Global
From €26424EUR$27,500USD£22,721GBP
- Report
- July 2019
- 775 Pages
Global
From €26424EUR$27,500USD£22,721GBP
- Report
- April 2024
- 132 Pages
Global
From €913EUR$950USD£785GBP
- Report
- March 2021
- 202 Pages
Global
From €3511EUR$3,654USD£3,019GBP
- Report
- May 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,956GBP
- Book
- January 2014
- 944 Pages
The Plasma Fractionation market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma fractionation is the process of separating plasma from whole blood, which is then used to produce a variety of therapeutic proteins and other products. These products are used to treat a variety of conditions, including hemophilia, immune deficiencies, and other rare diseases. Plasma fractionation also plays an important role in the production of vaccines and other biopharmaceuticals.
The Plasma Fractionation market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more
